Demand for testosterone therapy has soared in the United States with more men seeking to increase hormone levels in hopes of enhancing virility, strength and energy. Testosterone therapy has become a burgeoning business with direct-to-consumer men’s health platforms proliferating online in recent years. While testosterone therapy benefits some men, it can be harmful for others,...
A paper recently published in Endocrine Reviews looks to provide readers with an improved understanding in approaches to using hormone therapy to treat menopausal women. The review, by Valerie Flores, MD, and Lubna Pal, MD, of Yale School of Medicine and JoAnn Manson, MD, of Harvard Medical School, points out that hormone therapy remains the...
CEU 2021 Preview: Does Testosterone Therapy Have a Place in Treating Women?
At the all-virtual CEU 2021 in September, two contributors to a global consensus statement, Susan R. Davis, MBBS, FRACP, and Margaret E. Wierman, MD, will describe the use — and misuse — of giving women testosterone. This upcoming Clinical Endocrinology Update session sounds as if it could feature lively disagreement: “Endocrine Debate: Testosterone Therapy...Gut Instincts: The Endocrinologists Behind the 2020 Warren Alpert Foundation Prize
Endocrine Society members Daniel J. Drucker, MD, and Joel F. Habener, MA, MD, talk to Endocrine News about their 2020 Warren Alpert Foundation Prize-winning research of key intestinal hormones, as well as their distinguished careers and what this award means to them. On October 1, the Warren Alpert Foundation Prize will be presented in a...
Individuals Taking Class of Steroid Medications at High Risk for COVID-19
JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according...
In transgender men, what are the consequences of gender-affirming hormonal therapy on fertility? Led by Molly B. Moravek, MD, MPH, a team of researchers from the Center for Reproductive Medicine, in Ann Arbor, Mich., set out to answer that question as well as summarize the current literature on the topic of transgender men desiring reproduction...
Case Study Illuminates Metreleptin’s Possible Role in Improving Lipid and Glycemic Profiles
Researchers in Japan have detailed a case report in which a young woman who survived childhood cancer was treated with metreleptin supplementation to improve her acquired incomplete lipodystrophy and published their findings in the Journal of the Endocrine Society. The researchers, led by Ayako Nagayama, MD, and Kenji Ashida, MD, PhD, (Nomura Laboratory) of Kurume...
Targeting Patients with Pellets: A Look at Biodentical Hormones
Promoted to treat vague symptoms and conditions like “hormone imbalance,” custom-compounded bioidentical hormones are increasing in popularity — and problems. By the time the patient came into the care of endocrinologist Margaret Wierman, MD, she had already had her ovaries removed. She had presented to the obstetrics and gynecology department with very high testosterone levels...
